is a global leader in the development and implementation of innovative biological water and wastewater treatment solutions for the industrial and municipal markets. Aqwise’s family of biofilm-based solutions, which range from tailor-made process design to full turn-key projects, increase BOD and nutrient removal capacity utilizing various aerobic (AGAR® MBBR, AGAR® IFAS) and anaerobic (DACS®, DACS® DANA) processes. Aqwise has over 500 municipal and industrial (Pulp & Paper, Food & Beverage, Petrochemical, Pharmaceuticals) plants successfully implemented worldwide. Aqwise’s proprietary AGAR® technology is the result of more than a decade of intensive multidisciplinary research & development. Integrating Fixed Film and Suspended Growth processes, the unique AGAR® technology is considered as the ‘next generation’ biological wastewater treatment methodology. The AGAR® technology combines fully open and protected biomass carriers with highly efficient aeration and mixing techniques. The company is headquartered in Israel and has subsidiaries and offices in Latin America and Europe, Asia as well as commercial representation in North America, the Middle East and Africa.
Looking for a particular Aqwise employee's phone or email?
Aqwise Questions
The Aqwise annual revenue was $26.1 million in 2026.
1 people are employed at Aqwise.
Aqwise is based in Munich, Bavaria.
The NAICS codes for Aqwise are [333, 33].
The SIC codes for Aqwise are [358, 35].
